|
|
|
|
|
Click Here to return To Results
|
|
|
|
From November,1985 to June,1988,1007 outpatients with chronic non- rheumatic atrial fibrillation(AF)entered a randomized trial;335 received anticoagulation with warfarin openly,and in a double-blind study 336 received aspirin 75 mg once daily and 336 placebo.Each patient was followed up for 2 years or until termination of the trial.The primary endpoint was a thromboembolic complication(stroke,transient cerebral ischaemic attack,or embolic complications to the viscera and extremities). The secondary endpoint was death.The incidence of thromboembolic complications and vascular mortality were significantly lower in the warfarin group than in the aspirin and placebo groups,which did not differ significantly.5 patients on warfarin had thromboembolic complications compared with 20 patients on aspirin and 21 on placebo.21 patients on warfarin were withdrawn because of non-fatal bleeding complications compared with 2 on aspirin and none on placebo.Thus,anticoagulation therapy with warfarin can be recommended to prevent thromboembolic complications in patients with chronic non-rheumatic AF. |
|
(click to filter results - removes previous filter)
anticoagulant,complications of
anticoagulant,treatment
anticoagulant,treatment in CVD
arrhythmia,cardiac
aspirin
atrial fibrillation
cerebral embolism
cerebral embolism,cardiac origin
cerebrovascular accident
cerebrovascular accident,prevention of
coumarin
embolism
platelet inhibiting drugs
treatment of neurologic disorder
|
Click Here to return To Results
|
|